The top 100 stock
market authors
selected for publication
market authors
selected for publication
nova
»
Comments
» ARIA
You are currently following nova
Stop FollowingYou are no longer following nova
-
744
)
These Small Cap Cancer Drugmakers Have Big Growth Potential [View article]
Merck KGaA is IMCL's partner (now LLY) for Erbitux.
These Small Cap Cancer Drugmakers Have Big Growth Potential [View article]
> Stage I: 56%
> Stage 2: 34%
> Stage 3: 10%
> Stage 4: 2%"
This part does not make any sense. Early or later, we all will be dead.
Are you talking about PFS or OS?
What is the time-interval? Is it 1-yr overall surviving or what?